| Product NDC: | 55289-352 | 
| Proprietary Name: | Prednisone | 
| Non Proprietary Name: | Prednisone | 
| Active Ingredient(s): | 20 mg/1 & nbsp; Prednisone | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 55289-352 | 
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA040392 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20030212 | 
| Package NDC: | 55289-352-09 | 
| Package Description: | 9 TABLET in 1 BOTTLE, PLASTIC (55289-352-09) | 
| NDC Code | 55289-352-09 | 
| Proprietary Name | Prednisone | 
| Package Description | 9 TABLET in 1 BOTTLE, PLASTIC (55289-352-09) | 
| Product NDC | 55289-352 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Prednisone | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20030212 | 
| Marketing Category Name | ANDA | 
| Labeler Name | PD-Rx Pharmaceuticals, Inc. | 
| Substance Name | PREDNISONE | 
| Strength Number | 20 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes |